| Overview |
| bs-2419R |
| KIR2DL1 Polyclonal Antibody |
| WB, ELISA, IHC-P, IHC-F, IF(IHC-P), IF(IHC-F), IF(ICC), ICC |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CD158a/KIR2DL1 |
| 201-300/348 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 3802 |
| Cell membrane |
| Killer cell immunoglobulin-like receptor 2DL1; CD158A; Killer cell immunoglobulin like receptor 2DL1; MHC class I NK cell receptor; Natural killer associated transcript 1; NKAT 1; NKAT-1; NKAT1; p58 natural killer cell receptor clones CL-42/47.11; p58 NK receptor; p58.1 MHC class I specic NK receptor; CD158 antigen-like family member A; KI2L1_HUMAN; Natural killer-associated transcript 1; p58 NK receptor CL-42/47.11; p58.1 MHC class-I-specic NK receptor; CD158a. |
| The KIR family consists of transmembrane glycoproteins of the Ig superfamily expressed on natural killer (NK) cells and a subset of human T cells. KIR2DL1 is a receptor on human NK cells for HLA-C alleles. It inhibits the activity of NK cells thus preventing cell lysis. |
| Application Dilution |
| WB |
1:300-5000 |
| ELISA |
1:500-1000 |
| IHC-P |
1:200-400 |
| IHC-F |
1:100-500 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
| ICC |
1:100-500 |
Powered by Bioz